We investigated the role of intercellular adhesion molecule-1 (ICAM-1) in the adhesion of polymorphonuclear neutrophils (PMN) to classic antineutrophil cytoplasmic antibody (C-ANCA)-treated endothelial cells, independently of cytokines. Human umbilical vein endothelial cells (HUVEC) grown to confluence in cytokine-free conditions were stimulated with C-ANCA sera and affinity-purified anti-proteinase 3 antibodies (PR3) from Wegener's granulomatosis (WG) patients. Non-activated PMN were added to treated HUVEC and adhesion was measured. In parallel experiments, treated HUVEC were fixed and ICAM-1 and E-selectin were assayed by cyto-ELISA; in other experiments anti-ELAM-1 and anti-ICAM-1 antibodies were assessed. In this in vitro model, adhesion of non-activated PMN to anti-PR3-stimulated HUVEC was enhanced. Adhesion was greater with anti-PR3 antibodies than with control and normal immunoglobulins, and correlated with the level of anti-PR3 antibodies. Neutralization of anti-PR3 antibodies by neutrophil azurophilic granule proteins abolished adhesion. This adhesion increased at the fourth hour after simulation, peaked at the twelfth hour and then decreased. This phenomenon occurred mainly through endothelial expression of ICAM-1 (the main counter-receptor for integrins, involved in firm PMN adhesion and migration) and E-selectin on HUVEC membranes. Anti-adhesion molecule antibodies inhibited this adhesion. This work supports the hypothesis of a direct effect of C-ANCA in endothelial stimulation, namely, on endothelium-PMN adhesion, and strengthens the major role of ICAM-1, directly involved in firm sticking of PMN to HUVEC, besides E-selectin. C-ANCA upregulate endothelial adhesiveness and thus participate in inflammatory reactions by providing endothelial adhesive structures for neutrophils. This might be one of the first steps leading to clinical expression of the disease. These results provide new insights into the pathogenesis of C-ANCA-related diseases.
T value of classic antineutrophil cytoplasmic antibodies (C-ANCA) as a diagnostic and prognostic marker of vasculitis [1, 2] , especially in Wegener's granulomatosis (WG), is well documented [1] [2] [3] . Although C-ANCA are thought to play a key role in the pathogenesis of WG [4] [5] [6] , their mode of action is still hypothetical [7] . A number of studies have shown that the lesions observed in this disease are secondary to leucocyte activation, namely, when associated with increased levels of tumour necrosis factor alpha (TNF-a) [7] [8] [9] . C-ANCA induce polymorphonuclear neutrophil (PMN) degranulation and oxidative burst, after priming with TNF-a [8] ; this effect seems to occur through the Fc gamma receptor of the PMN membrane [9] . Human umbilical vein endothelial cells (HUVEC) treated with TNF-a are lysed by PMN [10] in the presence of C-ANCA; priming PMN with TNF-a enhances this effect.
Recently, it has emerged that C-ANCA can also stimulate HUVEC leading to the expression of endothelium leucocyte adhesion molecule-1 (ELAM-1) [11, 12] . These results suggest that the target of C-ANCA might be both endothelial cells and leucocytes, supporting the idea that HUVEC could express proteinase 3 (PR3), the target for C-ANCA, on the endothelial membrane [13, 14] .
Since endothelial cells play a key role in adhesion and as E-selectin is only involved in rolling of PMN along the endothelial walls, and is not sufficient by itself to induce vascular lesions, we tested the hypothesis that C-ANCA could stimulate HUVEC to express intercellular adhesion molecule-1 (ICAM-1) involved in firm endothelial adhesion of PMN [15] .
We postulated that an in vitro model of endothelial cell adhesion to PMN, in the presence of C-ANCA and in the absence of cytokine stimulation, could help to determine the role of C-ANCA in endothelial stimulation. We thus investigated the adhesion of unprimed PMN from healthy subjects to C-ANCAstimulated HUVEC and the involvement of ICAM-1 on those cells in the absence of cytokine stimulation; we also confirmed the involvement of E-selectin in this adhesion.
MATERIALS AND METHODS

Reagents
Hank's solution (HBSS), Fungizone (250 mg/ml), trypsin-EDTA and streptomycin were from Gibco (France). Colimycin (10 6 IU/ml) was from Roger Bellon (France). Collagenase (type CLS-1) was from Worthington Biochemical Co. (Freehold, NJ, USA). Culture medium (M199 with Earl salts) was from Eurobio (France). Phorbol myristate acetate (PMA), lipopolysaccharide (LPS), ATP Na 2 , Triton X-100, orthodianisidine, phenylmethylsulphonyl fluoride (PMSF), orthophenylenediamine (OPD) and EGTA Submitted 18 February 1996 ; revised version accepted 10 February 1997.
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were from Sigma (St Louis, MO, USA). Bactogelatin was from Difco (Detroit, MI, USA). Penicillin (10 6 IU/ml) was from Diamant (Puteaux, France). Dextran T 500 was from Merck (Darmstadt, Germany). Interleukin (IL) 1a and b and TNF-a were from Genzyme (France). Fetal calf serum was from Institut Jacques Bois (Reims, France), human albumin was from Bio-Transfusion (Roissy, France). DEAE-Sephacel, Dextran T 500 and CNBR-activated Sepharose were from Pharmacia (Sweden). Culture dishes and plates were from Corning (Strasbourg, France). ELISA tests were purchased from Bio Advance (Emerainville, France) for anti-PR3, anti-MPO (myeloperoxidase), anti-DNA, anti-SSA (anti-Ro) and anti-SSB (anti-La), from Medgenix Diagnostics (Fleurus Belgique) for TNF-a, and from Chromogenix AB (Sweden) for endotoxin. Mouse monoclonal anti-adhesion molecule antibodies (anti-ICAM-1, anti-ELAM-1), Fc fragments from irrelevant IgG and control anti-IgG1 were from Immunotech (Marseille, France). Biotinylated goat anti-mouse antibodies and peroxidase-conjugated streptavidin were from Amersham Life Science (France).
Cell preparations (HUVEC and PMN)
Endothelial cells were harvested from human umbilical cord veins with 0.05% collagenase [19, 20] . Cells from five donors were pooled and grown to confluence in Petri dishes coated with bactogelatin, containing M199 medium and Earl salts, supplemented with 20% fetal calf serum, -glutamine (2 m), penicillin (50 IU/ml), streptomycin (50 mg/ml) and fungizone (50 mg/ml) at 37°C in a 5% CO 2 incubator (Haereus, France). The medium was changed every second day until confluence. HUVEC were identified by phase-contrast light microscopy showing the typical cobblestone monolayer appearance of the cells and their ability to release von Willebrand factor [19, 21] . Cells were harvested after trypsin-EDTA digestion and seeded in 24-or 96-well gelatin-coated plates. We only used monolayers of tightly confluent secondary cultures. Cell viability was q96%. PMN were isolated from citrated blood of numerous healthy donors and purified as described elsewhere [19, 22] by a two-step process (2% dextran sedimentation and Ficoll-paque density gradient centrifugation). Preparations contained q97% PMN and viability (trypan blue exclusion) was q95%. As these PMN expressed L-selectin, they were considered as being not activated [19, 23] .
Purification of PR3
Extraction of azurophilic granule proteins from PMN was performed as described by Borregaard (as in [24] [25] [26] ) by nitrogen cavitation (Parr Instrument, Moline, USA) and percoll gradient sedimentation. Purification of PR3 was performed as described by Baslund et al. [31] . Azurophilic granules were lysed in 1% Triton X-100 overnight at 4°C and sonicated on ice. The material containing PR3 was dialysed against equilibration buffer (0.05  Tris-HCl, pH 8.5, 1% NaN 3 ) and applied on the top of a DEAE-Sephacel column. Bound material was eluted (1.5 ml fractions) with elution buffer (0.05  Tris-HCl, pH 8.5, 1  NaCl, 1% NaN 3 ); PR3 was present in the first peak (fractions 45-55). Fractions were tested for PR3, pooled, concentrated on a centrikon membrane and dialysed overnight in 0.05  NaAc (pH 4.5), 0.05  NaCl, 1% octylglycoside, 1% NaN 3 and then applied to a S-200 column. Purified PR3 was tested by ELISA and SDS-PAGE analysis. Purified PR3 was then coupled to CNBR-activated Sepharose 4B following the manufacturer's instructions. Quantification was achieved by weight quantification and ELISA.
Patients and sera, purifications of immunoglobulins
Six patients with biopsy-proven WG were studied; all had active disease and multi-organ involvement, except for patient no. 6 who was in remission. WG patients were tested for ANCA by indirect immunofluorescent assay (IIF) and ELISA [26, 28] . Despite intensive therapy (immunosuppressive drugs, corticosteroids and plasma exchanges) patients 2-5 died in the 3 months following blood sampling; in three cases, a second blood sample was obtained.
All sera were decomplemented (56°C, 45 min) and filtered. Immunoglobulins (Ig) were purified from WG patients' sera by protein G-Sepharose column chromatography [28] . After dialysis against phosphatebuffered saline (PBS), Ig were applied on the PR3-CNBR column, C-ANCA were eluted in PBS, 1  buffer NaCl, 1% NaN 3 , pooled and concentrated. The preparations were adjusted to 500 mg/ml and tested for LPS. Control sera were obtained from two patients with microscopic polyangiitis (MPA), a P-ANCA pattern on IIF testing and high titres of anti-MPO antibodies (1/2000); one patient with lupus, active glomerulonephritis (WHO class IV), antiphospholipid syndrome, anti-DNA and anticardiolipin antibodies; and a patient with primary Sjo¨gren's syndrome with anti-SSA and anti-SSB antibodies. Normal control sera (25 sera) were obtained from healthy blood donors at the blood bank and a batch of those sera was used in all experiments (all were heat inactivated, decomplemented and filtered). Immunoglobulins from those sera were extracted as previously described and tested for LPS. All preparations were tested for endotoxin contamination using the limulus amoebocyte assay (Sigma) and used only if endotoxin was Q0.05 ng/ml.
Adhesion assay
Twenty-four-well plates were washed with HBSS, stimulation media were placed in each well: negative control (HBSS), positive control [PMA 100 ng/ml; LPS 2 mg/ml or TNF-a 100 IU/ml (5 ng)], patient's sera or purified Ig (200 mg/ml). TNF-a, IL-1 and LPS are known as potent endothelial inducers of adhesion molecules [15] and were used as positive controls. Plates were incubated (5% CO 2 , 37°C) for precise times. Endothelial FcgR were saturated with either 10% normal human sera or Fc fragment from human IgG. PMN from various donors were added (10 6 /ml in each well) to washed HUVEC (to discard stimulants). After centrifugation (120 g, 1 min, 4°C) and 15 min contact, free PMN were discarded by washing with HBSS. Adherent PMN and HUVEC were harvested, lysed in 1% Triton X-100 and sonicated on ice. MPO activity in adherent fractions was measured as previously described [19] . Briefly, enzyme activity (specific for PMN) was measured in citrate buffer (pH 5.5, 0.1  citric trisodium salt, 0.1  citric acid), orthodianisidine (10 mg/l ml water) and H 2 O 2 (100 ml/ 10 ml citrate buffer). The kinetics of orthodianisidine oxidation in the presence of MPO was measured at 460 nm on a spectrophotometer. PMN adhesion was calculated by dividing the concentration of MPO in each well by the concentration in a control containing 10 6 /ml PMN. The standard curve relating the MPO activity to the number of PMN is linear; the DD0/min for 10 6 PMN is 8. HUVEC do not contain MPO [19] .
Measurement of endothelial expression of ICAM-1 and ELAM-1
ICAM-1 and E-selectin were measured as described by Tomczok et al. [25] with minor modifications. Briefly, HUVEC were cultured on 96-well gelatincoated plates as described, washed after various time of stimulation, fixed with glutaraldehyde (0.1%, 20 min, 4°C), saturated for 1 h at room temperature (50 m Tris-HCl, 150 m NaCl, 1% gelatin, 1% H 2 O 2 , pH 7.6) and washed twice in 0.01% PBS-Tween. Mouse anti-human ICAM-1, or anti-human E-selectin, or control anti-human IgG 1 , were added to each well, incubated for 1 h at room temperature and washed twice in PBS-Tween. The reaction was amplified with a biotinylated goat anti-mouse antibody (1/1000) and streptavidin/peroxidase [1/2500 in HBSS, 1% bovine serum albumin (BSA)]. After adding OPD, the reaction was stopped (2  H 2 SO 4 ). Plates were read at 450 nm and results expressed with an index established as follows: OD well − OD control IgG/OD control − OD control IgG. In this way, normal sera have an arbitrary value of one.
Other biochemical assays
Anti-PR3, anti-MPO, anti-DNA, anti-SSA, anti-SSB, anticardiolipin antibodies, as well as TNF-a and endotoxin, were assayed using commercial ELISA kits. IL-1a and b were assayed as described by Ferrua et al. [27] . Chemoattractant activity in all sera was screened for as described by Nelson et al. [29] under agarose gels. Anti-endothelial cell antibodies (AECA) were assayed on cyto-ELISA using confluent cultured human endothelial cells as previously described [30] .
Statistical analysis
Each value is the mean of at least nine measurements for each patient (WG, control and normal patients) performed on different culture plates, with PMN from various donors. Statistical analyses were performed using Statwork software to calculate means, standard deviations (mean 2 ..), as well as correlation curves.
Student's t-test was used to identify statistical significance (5%).
RESULTS
ANCA testing: IIF and anti-PR3 ELISA
When tested with the IIF assay, all WG patients (except patient no. 6) exhibited a C-ANCA pattern (titre range 1/400 to 1/800). All the six patients had anti-PR3 antibodies (ELISA) (titre range 12-82 ELISA units; normal value Q10); patient no. 6 was just over the limit of negative anti-PR3 antibody titres (12 units). For all WG patients, tests for the following autoantibodies were negative: anti-DNA, anti-MPO, anti-SSA, anti-SSB and anticardiolipin. All the control and normal sera were anti-PR3 negative.
Cytokine levels in patients' sera
Circulating levels of endotoxin and cytokines were determined in the sera and Ig used for stimulation. All but two sera were negative for TNF-a (WG patients nos 3 and 4, mean value 6 pg/ml). As all sera were heat inactivated, this TNF-a had no biological effect [32] . The mean value of IL-1a was 2 2 0.6 pg/ml, and screening for IL-1b was negative. The mean value of LPS was 12 2 16 pg/ml (range 0-40 pg/ml), i.e. below the threshold of biological activity. None of the sera and none of the purified Ig extracted from the patients, controls and normal sera had chemoattractant activity for PMN on agarose gel. The purified Ig extracted from the patients, control and normal sera were all devoid of cytokines (as measured for TNF-a, IL-1a and b), endotoxin and chemoattractant activity. All the sera (WG patients, control and healthy patients) and the purified Ig extracted from all those patients were tested for anti-endothelial cell antibodies [30] . None of them, except the patient with systemic lupus erythematosus and the patient with systemic Sjo¨gren's syndrome, had the so-called 'anti-endothelial cell antibodies'; these two patients were used as positive controls for adhesion [34] . (Fig. 1A and B) PMN adhesion to C-ANCA-stimulated HUVEC was measured following a stimulation kinetic of adhesion: after various times of stimulation (0.5, 4, 12 and 24 h of incubation), adhesion was measured as described. For each patient, nine measurements were performed on different plates, with PMN from various donors. Those values for each WG patient (each one being measured in duplicate, at least three times at four different hours) are not reported, but the mean value was calculated for the WG patients after testing adhesion using whole sera, and affinity-purified C-ANCA, which are represented in Fig. 1A and B. Optical controls (phase-contrast light microscopy) performed during adhesion procedures showed that PMN were uniformly adherent to HUVEC. Figure 1A shows the means of the curves of adhesion after stimulation with sera and affinity-purified C-ANCA from WG patients (1) (2) (3) (4) (5) , as compared with a batch of normal healthy patients with PMA Fig. 1-(Caption opposite) .
Adhesion
F. 1.-PMN adhesion to WG sera and affinity-purified Ig-stimulated HUVEC. HUVEC were variously treated, as described further, for 0.5, 4, 12 and 24 h during incubation at 37°C in 5% CO2, and then incubated for 15 min with PMN; adhesion was then measured as described in Materials and methods. All WG sera and control sera were diluted 1/5 in M 199 medium, then incubated with endothelial cells. Purified immunoglobulins were tested after being adjusted to 500 mg/ml. The mean value for WG patients (obtained after stimulating endothelial cells with sera) is given (open square, black bold line). The mean value for WG patients (after endothelial stimulation with affinity-purified Ig: black square, grey bold line) is also reported for comparison in this part of the figure. Results given are the mean of at least nine measurements on different plates for each WG patient with various PMN donors. *P Q 0.05 and **P = 0.05 compared to normal sera. (A) Comparison between the mean adhesion value obtained with WG patients (WG patients' sera and affinity-purified Ig from WG patients) compared with 'positive controls', i.e. PMA 100 ng/ml, LPS 2 mg/ml and TNF-a 100 IU/ml (5 ng/ml) and a batch of normal patients. (B) Comparison between the mean adhesion value obtained with WG patients (sera from WG patients and affinity-purified Ig from WG patients) compared with control disease patient (lupus patient, MPA patients, Sjo¨gren patient) and WG patient no. 6 (in remission).
purified C-ANCA from WG patients (1-5), as compared with disease control patients. The mean adhesion curve for the WG patients (after endothelial stimulation with sera and purified Ig) allows comparison with adhesion obtained from other stimulants or with disease controls (i.e. Ig from lupus, MPA and Sjo¨gren patients, containing anti-MPO, anti-DNA, anti-SSA and anti-SSB).
As shown, adhesion after endothelial stimulation with C-ANCA-containing sera and affinity-purified C-ANCA increased at the fourth hour, peaked at the twelfth hour, and then decreased. PMN adhesion to HUVEC was stronger with anti-PR3-positive sera (WG sera) than with healthy normal sera, and was stronger with anti-PR3-positive purified Ig than with purified Ig from healthy normal sera (Fig. 1A) , these values being statistically significant at 4, 12 and 24 h, except for WG no. 6 (quiescent disease). PMN adhesion to HUVEC is stronger after anti-PR3 sera or Ig stimulation than with any other disease control sera or Ig (Fig. 1B) , the values being statistically significant after 12 and 24 h of stimulation. (Fig. 2) C-ANCA anti-PR3 Ig modified PMN adhesion to stimulated HUVEC proportionally to their dilution. In contrast, dilution of normal sera or Ig did not modify adhesion, which remained at around 11%. WG patients' sera or Ig diluted 1/10 did not induce significantly different adhesion (13 2 4%) from normal control sera (11 2 3%) after 12 h, whereas adhesion was 35 2 6% at 1/5 dilution and 42 2 7% at 1/2 dilution, after 4 h of stimulation. There was a direct relationship between the ELISA titre of anti-PR3 and percentage PMN adhesion to HUVEC after 12 h (Fig. 2) . This has been observed in whole sera and in purified Ig. There was a linear correlation between the two parameters (r = 0.97; P = 0.001).
Dilution of ANCA
100 ng/ml, with LPS 2 mg/ml or TNF-a 100 IU/ml (5 ng). Figure 1B shows the means of the curves of adhesion after stimulation with sera and affinity- HUVEC were cultured in 96-well gelatin-coated plates and stimulated with C-ANCA sera at 4, 12 and 24 h as described in Fig.  1 . Cells were fixed (glutaraldehyde 0.1%) and saturated in TBS gelatin, then a mouse anti-human ICAM-1 monoclonal antibody was added to each well for 1 h at room temperature; the reaction was amplified with goat anti-mouse antibody and streptavidinperoxidase. Plates were read at 450 nm as described in Materials and methods. Results are the mean of eight measurements, on different plates.°P = NS and *P Q 0.05 when compared to normal sera. Results are given for TNF-a (white dotted area), IL-1 (grey dotted area), WG patients nos 1-5 (black area), WG no. 6 (white area) and normal sera (white hatched area). Plates were read at 450 nm and results expressed with an index established as follows: OD well − OD control IgG/OD control − OD control IgG. In this way, normal sera always have an arbitrary value of one.
Inhibition tests (Fig. 3) Increasing concentrations (0.35, 0.7 and 1.4 mg/ml) of azurophilic granule proteins were incubated with WG sera or purified Ig, for 1 h at 37°C; the supernatants were ultracentrifuged and tested for adhesion-stimulating activity. ELISA titres of anti-PR3 antibodies after incubation with granulophilic extracts declined proportionally to the amount of azurophilic granule protein added (data not shown) with a good correlation between the two parameters (r = 0.965). No detectable cytotoxicity (trypan blue exclusion) was noticed on endothelial cells after stimulation in such conditions. As shown in Fig. 3 , adhesion with these 'inhibited' sera or Ig was reduced, due to inhibition of anti-PR3 by PR3 contained in the granules (each point is the mean of six measurements). Statistical analysis of the two parameters showed a negative correlation (r = 0.950).
Expression of adhesion molecules (Figs 4 and 5)
Expression of adhesion molecules (ICAM-1 and E-selectin) induced either by serum or by purified immunoglobulins on the HUVEC membrane was studied by means of cyto-ELISA and measured in terms of peroxidase activity. In Figs 4 and 5 are represented the results of HUVEC stimulation by WG patients' sera; they produced an increased expression of ICAM-1 (Fig. 4 ) and E-selectin (Fig. 5) . ICAM-1 expression started at the fourth hour, peaked at the twelfth hour and then declined. In contrast, TNF-a and IL-1 induced persistently strong expression after the twelfth hour. The expression of E-selectin was maximal at 4 h after stimulation and then declined. The intensity of E-selectin expression induced by WG sera was lower than that induced by TNF-a and IL-1, but higher than that induced by normal sera at 4 h after stimulation (P Q 0.05).
Anti-adhesion molecule monoclonal antibodies
Inhibition tests were performed to assess the role of each adhesion molecule detected after HUVEC stimulation with anti-PR3 antibodies. Using a monoclonal antibody against each adhesion molecule (diluted in 1% human albumin), added at the end of the stimulation period for 20 min before adding PMN, adhesion was inhibited by 040% at the fourth hour F. 3.-Relationship between adhesion and the amount of azurophilic granule protein used to neutralize sera from WG patients. After neutralizing pooled sera from the WG patients with azurophilic granule protein (as described in Materials and methods), the supernatants were tested for stimulation of adhesion, as described in Fig. 1 . Note the correlation between the decreasing adhesion and the increasing amount of protein added to each serum sample (needed to neutralize anti-PR3 antibodies). Y-axis: % of adhesion; X-axis: amount of azurophilic granule protein. Curve: Y = −15.592X + 32.8, r = 0.95. Each point is the mean of at least three measurements. F. 5.-Expression of ELAM-1 on C-ANCA-stimulated-HUVEC. HUVEC were cultured in 96-well gelatin-coated plates and stimulated with C-ANCA sera at 4, 12 and 24 h as described in Fig. 1 . Cells were fixed (0.1% glutaraldehyde) and saturated in TBS gelatin, then a mouse anti-human E-selectin monoclonal antibody was added to each well for 1 h at room temperature; the reaction was amplified with goat anti-mouse antibody and streptavidin-peroxidase. Plates were read at 450 nm as described in Materials and methods. Results are the mean of eight measurements on different plates.°P = NS and *P Q 0.05 when compared with normal sera. Results are given for TNF-a (white dotted area), IL-1 (grey dotted area), WG patients nos 1-5 (black area), WG no. 6 (white area) and normal sera (white hatched area).
pointed to a direct role of anti-PR3 in upregulating HUVEC adhesiveness to PMN in this model.
In order to confirm those results, we used affinity-purified anti-PR3 antibodies and reproduced the observed effect on adhesion, with the same pattern as previously. This is shown by the slight, but not statistically significant, difference observed between the adhesion curve using whole sera and purified Ig. The degree of adhesion observed with C-ANCA in this model was smaller, however, than with PMA or LPS, and TNF-a, known as potent endothelial inducers of adhesion molecules [15] . Control Ig with anti-DNA, anti-MPO, anti-SSA, anti-SSB or anticardiolipin antibodies exhibited a pattern of adhesion different from that yielded by anti-PR3-Ig with a lower degree of adhesion. Adhesion induced by those Ig culminated at the fourth hour (with various values) and then declined rapidly. The adhesion induced by anti-PR3 antibodies was slightly delayed compared with TNF-a and LPS, opening up the possibility that a soluble factor could mediate this adhesion, as suggested by Carvalho et al. [34] . Indeed, we have recently found that C-ANCA can induce the endothelial expression of IL-1a, which in turn activates endothelial cells (M. De Bandt, accepted for publication in Arthritis Rheum, 1997). It is thus conceivable that IL-1a could mediate PMN adhesion to C-ANCA-stimulated HUVEC, explaining this delay.
The mechanisms underlying the adhesion induced by anti-PR3 were analysed. Membrane expression of E-selectin was maximal at the fourth hour after stimulation, thereafter decreasing until the twentyfourth hour. However, the role of E-selectin is limited to the rolling along endothelial walls, and cannot by itself lead to vascular damage [13, 15] . Adhesion molecules such as ICAM are involved in firm adhesion and sticking of PMN to endothelial cells, and then in transvascular migration [15] . We show in this study that endothelial expression of ICAM-1 (involved in firm PMN adhesion) is enhanced in this model. The kinetics is different from that of E-selectin: peak expression occurred at the twelfth hour and then slowly fell. The peak of PMN adhesion at 12 h can thus be explained by the maximum expression of ICAM-1 at this time. The role of these molecules was assessed with anti-adhesion molecule antibodies, which showed that both were involved: selective blockade of one only partially inhibited adhesion.
We observed in C-ANCA-stimulated HUVEC a relationship between adhesion and expression of those two adhesion molecules. At the fourth hour, the adhesion promoted by TNF-a is higher than that promoted by C-ANCA and correlates with E-selectin expression, whereas at the twelfth hour there is a correlation between adhesion and ICAM-1, but not with E-selectin. At the twelfth hour, the difference in adhesion between C-ANCA and TNFa-stimulated cells and in ICAM expression was the same. At the twenty-fourth hour, there was a discrepancy between ICAM expression and adhesion induced by TNF-a, whereas with C-ANCA as stimulant, ICAM-1 with the anti-ICAM-1 antibody, and by 052% with the anti-ELAM-1 antibody. After 12 h, adhesion was inhibited by 24 2 7% with the anti-ICAM-1 antibody and by 11 2 5% with the anti-ELAM-1 antibody. The control mouse anti-human IgG1 did not modify adhesion.
DISCUSSION
We show here that PMN adhesion to HUVEC was increased by stimulation of HUVEC with C-ANCAcontaining sera and anti-PR3 affinity-purified Ig, and that this adhesion involves the expression of ICAM-1 and E-selectin. This effect began 4 h after the beginning of stimulation, peaked at the twelfth hour and then declined. This pattern was observed with sera from WG patients with active disease, but not with the patient in the quiescent phase (no. 6); in this latter case, the adhesion pattern was similar to that of normal sera. In our model, the role of cytokines was ruled out and C-ANCA were probably responsible for the observed effect. We found a good correlation between the percentage of induced adhesion and the level of anti-PR3 antibodies, suggesting a direct link between the C-ANCA autoantibody and adhesion. Increasing dilutions of C-ANCA-positive sera reduced PMN adhesion proportionally, suggesting that a soluble factor was involved in the adhesion process. All the WG sera were positive for anti-PR3 antibodies and contained no other detectable autoantibodies. Neutralization assays of anti-PR3 with PR3 from PMN azurophilic granules, in which the fall in anti-PR3 antibody titres correlated with the fall in adhesion, expression and PMN adhesion correlated at this time; this cannot be explained only by ICAM and ELAM expression.
Our results suggest a direct role of C-ANCA in endothelium-PMN adhesion. ANCA seem to upregulate endothelial adhesiveness; the first step being PMN rolling induced by E-selectin, the second firm adhesion and transvascular migration, involving ICAM-1 as this was shown in other different cell models [15] . In this way, endothelial cells participate in inflammatory reactions by providing neutrophils with adhesive structures. This might be one of the first steps leading to clinical expression of the disease [7] . Moreover, the stimulatory role of C-ANCA on other cell types could also play a role [33] in the vasculitic process and in granuloma formation. This direct pathogenic role of C-ANCA also fits well with the correlation between the clinical manifestations of the disease and the level of anti-PR3 antibodies [3] [4] [5] . Nevertheless, a number of patients have high levels of circulating C-ANCA in the absence of clinical disease, so we believe that in vivo C-ANCA is unlikely to be the only factor involved in the process. In WG, local endothelial production of cytokines such as IL-1 or IL-8 is also responsible for expression of adhesion molecules. However, the proper role of C-ANCA in endothelial stimulation could explain the discrepancies between the blood levels of main cytokines such as TNF-a in WG patients and clinical manifestations [16] [17] [18] . The fact that 4/6 WG patients had no detectable circulating TNF-a at the time of severe relapses (leading to death) supports this explanation. This effect of C-ANCA could also explain the clinical outcome and the therapeutic benefit of removing such antibodies by means of plasmapheresis.
Further studies are needed to discover the target of C-ANCA on endothelium and the pathways (as well as the inside-out signalling and the secondary mediators) responsible for the endothelial response to C-ANCA. There is some controversy [13, 14] regarding the expression of PR3 (target for C-ANCA) on the endothelial cell membrane in response to cytokine stimulation in WG disease. King et al. [14] reported that cytokine-stimulated endothelial cells do not express PR3, whereas Mayet [13] reported that PR3 was expressed on HUVEC only after cytokine stimulation, but not in unstimulated HUVEC. We also did not detect PR3 on unstimulated HUVEC, but this could rely on various culture conditions (unpublished data). In our model, C-ANCA cannot react with the Fcg receptor (on endothelial cell membranes) as they were saturated with 10% normal human sera or Fc-IgG fragments. Moreover, Ig not directed against PR3 were without effect. The possibility of a conformational epitope (shared with PR3) and borne on HUVEC membrane is under question.
In conclusion, incubation of HUVEC with anti-PR3 antibodies enhanced the adhesion of non-stimulated PMN by inducing overexpression of ICAM-1 and E-selectin. This effect seems to be directly related to C-ANCA, independently of major cytokines such as TNF-a and IL-1, and chemoattractant factors. The effect disappears when C-ANCA are neutralized, and correlates with circulating levels of anti-PR3 autoantibody. This role of C-ANCA fits well with (1) the correlation between the clinical manifestations of the disease and the level of anti-PR3 antibodies, (2) the discrepancy between the blood levels of TNF-a and the clinical features of WG patients, (3) the parallel relationship between antibody titres and clinical outcome, and (4) the therapeutic benefit of removing such antibodies by means of plasmapheresis. Our results strengthen the role of ICAM, a major adhesion molecule, in PMN adhesion to ANCA-stimulated HUVEC and open new insights into the pathogenicity of the disease. A This work was supported by a grant from La Socie´teF ranc aise de Rhumatologie.
